Pacira BioSciences' Gross Profit rose 11.97% to $145.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $567.5 million, marking a year-over-year increase of 9.82%. This contributed to the annual value of $530.5 million for FY2024, which is 8.20% up from last year.
Per Pacira BioSciences' latest filing, its Gross Profit stood at $145.2 million for Q3 2025, which was up 3.57% from $140.2 million recorded in Q2 2025.
Over the past 5 years, Pacira BioSciences' Gross Profit peaked at $147.4 million during Q4 2024, and registered a low of $87.7 million during Q1 2021.
For the 3-year period, Pacira BioSciences' Gross Profit averaged around $131.0 million, with its median value being $133.6 million (2023).
Per our database at Business Quant, Pacira BioSciences' Gross Profit skyrocketed by 88.61% in 2021 and then declined by 8.69% in 2023.
Pacira BioSciences' Gross Profit (Quarterly) stood at $120.2 million in 2021, then dropped by 8.44% to $110.0 million in 2022, then rose by 21.37% to $133.6 million in 2023, then rose by 10.34% to $147.4 million in 2024, then grew by 11.97% to $145.2 million in 2025.
Its Gross Profit was $145.2 million in Q3 2025, compared to $140.2 million in Q2 2025 and $134.6 million in Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value